MAPT and Alzheimer disease: Blood-based phospho-tau 217 (P-tau 217) and phospho-tau 181 (P-tau 181) are sensitive and specific markers of AD pathology2–4, outperforming plasma amyloid-beta (Ab42/40), neurofilament light chain (NfL) and total tau2,3.